Arthritis drug reduced the risks of dying of coronavirus by nearly half in a small study

A new study from the University of Michigan found that tocilizumab, a rheumatoid arthritis drug, reduced the liklihood of death for coronavirus patients on ventilators by 45%.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news